Anterior Chamber Migration of Intravitreal Dexamethasone Implant in an Eye with Scleral-fixated Intraocular Lens.

Neha Goel,Reena Choudhry,Jyoti Batra,Aanchal Mehta

doi:10.18502/jovr.v15i4.7798

Abstract

This is a Photo Essay. Please download the PDF or view the article HTML.

Highlights

A 60-year-old woman with diabetes and hypertension presented with a decreased vision OD to 6/18 N10 due to cystoid macular edema (CME) following vitrectomy for removal of the dislocated posterior chamber intraocular lens (PCIOL) and scleral-fixated intraocular lens (SFIOL) implantation performed five months before
Suboptimal visual and anatomical results led us to inject DEX implant again, with care taken not to dilate the pupil fully at any time. She underwent four intravitreal DEX implants over the following year; best corrected visual acuity (BCVA) remained stable at 6/12 N8 with a clear cornea, intraocular pressure (IOP) < 20 mmHg in the absence of therapy, no recurrence of CME, and no anterior migration of the implant
As a precaution to minimize recurrent migration, the pupil size was kept reduced enough to cover the edge of the optic

Summary

Introduction

A 60-year-old woman with diabetes and hypertension presented with a decreased vision OD to 6/18 N10 due to cystoid macular edema (CME) following vitrectomy for removal of the dislocated posterior chamber intraocular lens (PCIOL) and scleral-fixated intraocular lens (SFIOL) implantation performed five months before. Received: 24-10-2018 Accepted: 29-07-2019 vitrectomized eye allowed the implant to migrate forward through the gap between the IOL edge and the pupil (Figure 1b).

Results

Conclusion